A Clinical Trial to Evaluate the Effects of a Supplement on Markers of Female Fertility

Part of paid clinical trials in Las Vegas, Nevada.

Sponsor
WeNatal
Study ID
NCT07740187
Status
Completed

Conditions

  • Female Infertility
  • Fertility
  • Hormonal Imbalance
  • Ovarian Reserve
  • Reproductive Health

Eligibility Criteria

Sex
ALL
Age
18 Years - 45 Years
Healthy Volunteers
Accepted

Interventions

  • WeNatal For Her Supplement — DIETARY_SUPPLEMENT
    All 40 participants take three capsules of the WeNatal For Her supplement daily in the morning with their first meal for three menstrual cycles.

Study Details

This study evaluates the effects of a daily dietary supplement (WeNatal For Her) on markers of female fertility, reproductive health, and sexual health over three menstrual cycles. Forty female participants who are currently trying to conceive will take three capsules of the supplement each morning with their first meal. The study is a single-arm, unblinded hybrid trial. Participants will complete questionnaires at Baseline and on Days 2-5 of Cycles 1, 2, and 3, and will attend a local Labcorp location for blood draws at Baseline and at Cycle 3. Primary outcomes include blood-based biomarkers of female fertility (e.g., AMH, FSH, Estradiol), while secondary outcomes capture self-reported perceptions of reproductive health, energy levels, mood, and overall well-being.

Key Dates

First listed
Jul 31, 2026
Start date
Apr 15, 2025
Status verified
Jul 2026
Primary completion
Feb 12, 2026
Completion
Feb 12, 2026

Study Design

Enrollment
40 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: WeNatal For Her Supplement

Primary Outcome Measure

Change in Anti-Müllerian Hormone (AMH) [ Time Frame: Baseline and Day 2-5 of Cycle 3 ]

Locations (1)

FacilityCityStateZIPSite coordinators
CitruslabsLas VegasNevada89118-

Find similar trials in Las Vegas, NV

By research site
Citruslabs· Las Vegas, NV

Related Studies